- Home
- AUMN vs NCNA Comparison
AUMN vs NCNA Comparison
Compare AUMN & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUMN
- NCNA
- Stock Information
- Founded
- AUMN 1996
- NCNA 1997
- Country
- AUMN United States
- NCNA United Kingdom
- Employees
- AUMN N/A
- NCNA N/A
- Industry
- AUMN Precious Metals
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- AUMN Basic Materials
- NCNA Health Care
- Exchange
- AUMN Nasdaq
- NCNA Nasdaq
- Market Cap
- AUMN 4.1M
- NCNA 4.4M
- IPO Year
- AUMN 1997
- NCNA 2017
- Fundamental
- Price
- AUMN $0.28
- NCNA $1.49
- Analyst Decision
- AUMN Strong Buy
- NCNA Buy
- Analyst Count
- AUMN 1
- NCNA 2
- Target Price
- AUMN $1.50
- NCNA $25.00
- AVG Volume (30 Days)
- AUMN 177.5K
- NCNA 138.4K
- Earning Date
- AUMN 11-26-2024
- NCNA 11-26-2024
- Dividend Yield
- AUMN N/A
- NCNA N/A
- EPS Growth
- AUMN N/A
- NCNA N/A
- EPS
- AUMN N/A
- NCNA N/A
- Revenue
- AUMN $2,812,000.00
- NCNA N/A
- Revenue This Year
- AUMN $254.39
- NCNA N/A
- Revenue Next Year
- AUMN $32.53
- NCNA N/A
- P/E Ratio
- AUMN N/A
- NCNA N/A
- Revenue Growth
- AUMN N/A
- NCNA N/A
- 52 Week Low
- AUMN $0.21
- NCNA $1.49
- 52 Week High
- AUMN $0.79
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- AUMN 39.57
- NCNA 34.09
- Support Level
- AUMN $0.29
- NCNA $1.53
- Resistance Level
- AUMN $0.41
- NCNA $1.66
- Average True Range (ATR)
- AUMN 0.03
- NCNA 0.09
- MACD
- AUMN -0.01
- NCNA 0.05
- Stochastic Oscillator
- AUMN 0.00
- NCNA -3.70
About AUMN Golden Minerals Company
Golden Minerals Co is an exploration stage company engaged in the mining, construction, and exploration of precious metals and mineral properties. It owns and operates Velardena and Chicago precious metals mining properties and associated oxide and sulfide processing plants in the State of Durango, Mexico, the El Quevar exploration property in the province of Salta, Argentina, and a diversified portfolio of precious metals and other mineral exploration properties located in or near historical precious metals producing regions of Mexico. The company's business is structured into two divisions, Mexico operations, and Corporate Exploration and Other.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.